Year-over-year earnings per share growth for the last twelve months: Immix Biopharma, Inc. (IMMX)

Immix Biopharma (IMMX) - corporate logo

The lack of stable cash flows due to the clinical testing stage makes Immix Biopharma, Inc. (IMMX) dependent on external financing, and the quarterly EPS growth trajectory on GURU.Markets reflects this risk, where this metric equals 20.70. The fundamentals are strengthened by diversified development platforms for high-margin oncology drugs and strict control over biocomponent supplies via redundant vendors to ensure uninterrupted research.

Immix Biopharma Inc. (IMMX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Immix Biopharma (IMMX)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Immix Biopharma, Inc., IMMX
Manufactured product of immixbio.com

Quarterly EPS growth measures the percentage change in net income per share compared to the same period last year, allowing investors to differentiate a growing business from stagnating assets. By analyzing the quarterly EPS growth trend, an investor can see the lack of operating profit for Immix Biopharma, Inc. (IMMX), as the company is in the clinical research stage and relies on external financing.

Competitors of Immix Biopharma, Inc.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP